本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2012/8/31 分钟阅读
Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT); Public Workshop
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to provide a forum to consider issues related to endpoints that can support drug development in the following disease areas: Eosinophilic esophagitis, pediatric and adult inflammatory bowel disease, and parenteral nutrition-associated liver disease.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →